July 17, 2024 11:06 AM EDTUpdated July 19, 02:00 PM
People

Cas­sa­va founder and CEO re­signs as fed­er­al probes progress

Max Bayer

Pharma Reporter

Cas­sa­va Sci­ences founder and CEO Re­mi Bar­bi­er is re­sign­ing amid two fed­er­al probes in­to the com­pa­ny, which said it’s look­ing for a new leader. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er part­ners with Flag­ship ge­net­ics start­up Quo­tient on heart and kid­ney drugs

Neu­ro­crine's schiz­o­phre­nia da­ta are good enough for Phase 3 — but maybe not enough to beat Karuna

Bay­er part­ners with RNA start­up launched out of Dana-Far­ber

Ex­clu­sive: Noetik rais­es $40M Se­ries A to ad­vance AI am­bi­tions in can­cer — with an un­like­ly lead in­vestor

No­var­tis part­ners with small North Car­oli­na biotech to make its bi­o­log­ics more 'con­ve­nien­t'

Cal­i­for­nia In­sti­tute for Im­munol­o­gy and Im­munother­a­py gets $120M gift for vac­cine, mi­cro­bio­me re­search

A service from the Financial Times